Oxaliplatin Accord 5 mg/ml koncentrat till infusionsvätska

DRUG2 trials

Sponsors

Karolinska University Hospital, Uppsala University Hospital

Conditions

Colorectal cancer with peritoneal metastasesResectable locally advanced squamous cell carcinoma (SCC) of the esophagus

Phase 2

COLOVERT – Conversion therapy in colorectal cancer with peritoneal metastases not amenable to upfront cytoreductive surgery and HIPEC: a phase II “pick-the-winner” open-label randomized trial

Not yet recruitingCTIS2026-526122-41-00

Uppsala University HospitalColorectal cancer with peritoneal metastases

Target: 60Updated: 2026-07-15

Phase 3

NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)

RecruitingCTIS2022-500966-82-00

Karolinska University HospitalResectable locally advanced squamous cell carcinoma (SCC) of the esophagus

Start: 2020-03-11Target: 235Updated: 2025-05-07